Leading strategy, sales& marketing, and business development activities for NMDP BioTherapies (formerly called Be The Match BioTherapies), a new venture of Be The Match/National Marrow Donor Program. Since assuming this role in 2018 (consultant in the same role in 2016 and 2017), have transformed NMDP BioTherapies from a relative unknown in the cell and gene therapy marketplace to a leading vendor to developers of both allogeneic and autologous cell and gene therapies.Grew the sales and business development team from two to eight professionals servicing the cell and gene therapy industry; instrumental in growing the internal operational delivery team to over 60 professionals with additional support from roughly an additional 70 FTEs.Have been integral to building a best in class vendor ecosystem to standardize and streamline both the clinical study and commercial CGT environments, resulting in accelerated access to new therapies. Track record of accomplishment: - Grew client list to over 65 cell and gene therapy developers (autologous and allogeneic); - Built a industry leading brand (brand recognition to begin with was virtually zero); - Envisioned and executed major partnerships with blue chip suppliers to solidify our reputation and ability to deliver in the market; - Met or exceeded goals every year. Have significantly increased the profile of this business in partnership with marketing, moving from a virtual unknown to an entrenched vendor and market influencer in the CGT space;In partnership with our cell and gene therapy operations group, have increased internal staffing support from roughly 15 FTEs to 60 FTEs over two years, reflecting a significant increase in the volume of work being delivered to cell and gene therapy clients;As a senior member of the leadership team, I was responsible for setting much of the vision and strategy for the organization. Excellent team leader.Have spoken at many leading CGT conferences.

- Co-Founded venture backed biopharma developing drugs for high unmet medical needs in reproductive health, with lead programs targeting the immunology of pregnancy (recurrent miscarriage (natural conception) and repeated implantation failure (assisted reproduction))- Closed $25M Series A venture financing with top tier venture firms (Burrill & Co., Vivo Capital, Prospect Venture Partners)- Closed $10M Series A follow on (existing investors + Rho Ventures)- Closed $18M Series B (existing investors + Novo Ventures)- Worked closely with venture capitalists to recruit highly experienced management team- Responsible for a significant portion of the company's operations, including managing the intellectual property portfolio, negotiating all contracts/CDAs, controller/treasury/finance functions (forecasting, budgets vs. actuals, cash management, BOD level reporting of financial forecasts and results, 409a valuations, preferred stock valuations, developing internal financial control processes, ongoing fundraising), administrative/HR (interviewing, hiring, and on-boarding of new employees, managing small executive team across four states)- Managed/oversaw primary market research with physicians and payers to better understand the prescribing and payment landscapes- Spearheaded and managed outreach to patient advocacy groups and key industry associations - Developed communications and public relations strategy- Involved heavily in development of regulatory strategy - Negotiated key supply agreements with large, multinational CMOs and CROs- Negotiated key services agreements with vendors in the supply chain as well as in the clinical operations arena- Negotiated licensing agreements- Involved very heavily in marketing the company to investment bankers to prepare a path towards an eventual public offering of stock - Readied the company's financial statements for public dissemination - Drafted key sections of the company's S-1

- Co-founded biopharmaceutical company targeting infertility and recurrent pregnancy loss- Secured $350,000 in non-dilutive seed funding (state grants, NIH grants)- Secured angel financing- Worked closely with state agencies and state financing organizations to ensure priority review of the company's proposals for early stage financing- Along with scientific co-founder, filed seminal patent that would form the basis for the company's eventual IP portfolio (14 issued patents in the US and Europe)- Secured orphan designation from the FDA Office of Orphan Products Development- Engaged with FDA along with co-founder from the earliest stages of the company. Composed and filed company's first IND and attended FDA meetings regarding same- Helped guide early development to position the company for broad commercial opportunities- Wrote and marketed business plan for an innovative approach to re-purposing biologics that would eventually underpin venture financing (see Nora Therapeutics, Inc.)

- Strategic marketing and strategic planning for paradigm-shifting fiber optics technology- Supported C-level executives and sales and marketing department with analyses of market opportunities and long term strategic opportunities- Designed award winning interactive case study for salesforce training. Received best in class award from the Corporate Executive Board, Sales Executive Council, 2001- Designed revenue generating professional services and maintenance plan. Successfully launched by company and became a significant new source of revenue for the company- Researched and wrote business plans and market entry strategies for new markets (international and domestic)- Developed and conducted market research studies and financial analyses to help define product development to meet market need- Worked with senior management to define business direction based on highly volatile market conditions- Weekly meetings with senior leadership to assess achievement of business plans, shortfalls, and means for remedying shortfalls- Designed competitive intelligence database to support sales efforts- Designed corporate intranet-based competitive intelligence database detailing strengths and weaknesses of competitor product offerings- Developed product roadmap in accordance with customer demands, competitor product offerings, and core competencies of the company- Helped design marketing presence at trade shows and staffed large conference booths

- Helped identify opportunity to utilize the internet for personal, non profit, fundraising- Wrote and submitted business plan and entered into Haas School of Business competition (finalist)- Formed company, built legal/advisory committees, recruited management team (sweat equity compensation)- Team worked to write code, position company in emerging marketplace- Built user base targeting a handful of high profile charities that rely on individuals to raise money- Negotiated terms of a buyout with publicly traded company (though market conditions precluded buyout itself)- Pledgepage still exists (see PledgePage.org) and has facilitated the raising of over $3M for a wide variety of causes

- Contracted services global firms of experts applying economic, finance, and quantitative principles to complex business and legal challenges- Patent and asset valuations for emerging and established technology companies - Researched comparable technologies and companies, assembled financial information regarding competitor product offerings and market valuations, wrote and presented reports suggesting likely valuation(s) and profit maximizing future strategic directions- Profitability analyses and business planning- Assessed potential markets for licensing technologies and valued potential royalty streams- Involved with management and strategic issues across an extremely wide variety of industries (energy, telecommunications, high technology, health care, financial services, retail)

- Recruited to start a telecommunications management consulting practice within the existing structure of one of the most highly respected and sought after energy consulting firms (Putnam, Hayes, & Bartlett) in the country- Built practice area from the ground up, generating over $1.5M in annual billings within two years- Developed strategic marketing initiatives/strategies to improve profitability- Created strategic planning documents- Conducted business valuations- Conducted due diligence on startup companies for venture capital firms- Advised non-telecom companies on potential revenue opportunities in the telecom industry (utility companies in particular)- Helped secure regulatory approval for proposed mergers (Department of Justice)- Assisted with the integration of the telecommunications practices of three merged firms (Hagler Bailly, Putnam Hayes & Bartlett, and Theodore Berry & Associates)- Publications (Greg Hallman and Chris McClain, “Real Options Applications to Telecommunications Deregulation,” Real Options: The New Investment Theory and its Implications for Telecommunications Economics (1999), Regulatory Economics Series, Kluwer Academic Publishers, Boston. James Alleman and Eli Noam, Editors; Steve George and Chris McClain, “Competitive Metering, Billing and Customer Services: An Analysis of Operational Issues (Part II),” Edison Electric Institute (1997); Steve George and Chris McClain, “Just a Phone Call Away,” Electric Perspectives (July/August 1998))

- Enrolled by the Pacific Bell Operating Committee in the Accelerated Development Program - an executive “fast track” program consisting of 27 managers identified as high potential future leaders- Team leader of and participant in many company-wide process redesign efforts- Recommended strategic and tactical plans in preparation for deregulation of the local markets- Developed expertise in pricing strategy- Built economic models that simulated business unit and company-wide profitability effects of proposed marketing and public policy initiatives- Developed pricing assessment methodology for new product development team- Presented analyses and recommendations on many occasions to executives and officers of the company

- Developed business strategies and business plans for startup and emerging companies- Co-managed business planning seminars for entrepreneurs- Conducted primary market research for clients to better understand the market- Prepared detailed competitor analyses to help guide early decision-making- Helped connect investors and entrepreneurs

- Researched and analyzed data in support of expert economic testimony in litigation- Constructed sophisticated financial models of client businesses- Developed training materials and a training program for new Analysts